Related Experiment Videos
Cranial computed tomography of malignant melanoma
AJR. American Journal of Roentgenology
|January 1, 1981
Summary
Cranial computed tomography (CT) effectively detects malignant melanoma brain metastases, often showing increased attenuation and contrast enhancement. Staging CT scans may benefit patients with advanced melanoma to identify occult cerebral involvement.
Area of Science:
- Neuroradiology
- Oncology
- Medical Imaging
Background:
- Malignant melanoma frequently metastasizes to the brain.
- Accurate detection of cerebral metastases is crucial for patient management and prognosis.
Purpose of the Study:
- To evaluate the efficacy of cranial computed tomography (CT) in detecting cerebral metastases from malignant melanoma.
- To characterize the CT findings associated with melanoma brain metastases.
Main Methods:
- Retrospective review of 275 cranial CT scans from 179 patients with malignant melanoma.
- Analysis of CT scan features, including precontrast attenuation and postcontrast enhancement.
- Correlation of CT findings with the presence and extent of bleeding within lesions.
Main Results:
- CT identified cerebral metastases in 93 of 101 patients with confirmed disease.
- Increased attenuation on precontrast scans was observed in 72% of metastases and enhanced postcontrast.
- Lesion density correlated with the extent of bleeding, with >20% red blood cells/HPF in hyperattenuating lesions.
- Occult metastases were found in 11% of patients without clinical brain involvement.
Conclusions:
- Cranial CT is a sensitive tool for diagnosing melanoma brain metastases.
- Characteristic CT findings include hyperattenuation and contrast enhancement, often associated with hemorrhage.
- Staging CT scans are recommended for patients with advanced or diffuse extracranial melanoma to detect asymptomatic cerebral metastases.